中國飛鶴(06186.HK)首日上市,超額認購約12.14倍
中國嬰幼兒配方奶粉龍頭企業中國飛鶴(06186.HK)今日在港交所主板掛牌正式上市。據招股結果公告所示,中國飛鶴的招股價最終定在7.5港元,交易單位為1000股,香港公開發售部分獲12.14倍超額認購,國際配售部分也獲超額認購,按招股價推算上市前的總市值約為670億港元。
財務數據顯示,中國飛鶴2016財年至2018財年總收益分別為37.24億、58.87億及103.92億元人民幣;淨利潤分別為4.06億元、11.6億元及22.42億元人民幣。截至2019年上半年,公司收入與淨利潤分別為58.92億元及17.51億元,同比增長34.37%及60.41%,兩者增長速度仍維持在較高水平。
資料顯示,創立於1962年的飛鶴是中國最早的奶粉生產企業之一,公司定位於高端市場,目前飛鶴旗下擁有超高端星飛帆、超高端臻稚有機等系列產品。根據弗若斯特沙利文報告,按2018年零售銷售價值計,飛鶴是中國最大的國內嬰幼兒配方奶粉集團,同時在國內外嬰幼兒配方奶粉集團中排名第二。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.